NewAmsterdam Pharma Company N.V. (NAMS) net assets (shareholders' equity)

Net assets · fiscal 2025
$683.43M

NewAmsterdam Pharma Company N.V. (NAMS) had net assets of $683.43M at the end of fiscal 2025 (December 31, 2025). That is 9.8% lower than the $757.50M of fiscal 2024. Figures as of 18 Nov 2026, 23:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$683.43M
Change on fiscal 2024
−9.8%
Highest on record
$757.50Mfiscal 2024
Lowest on record
-$113.82Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

NewAmsterdam Pharma Company N.V. net assets (shareholders' equity), in more detail

Across the 5 fiscal years on record (2021–2025), the highest was $757.50M in fiscal 2024 and the lowest -$113.82M in fiscal 2021.

History · 5 fiscal years

Net assets by fiscal year

NewAmsterdam Pharma Company N.V. net assets (shareholders' equity), year by year

NewAmsterdam Pharma Company N.V. (NAMS) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$683.43M 9.8% down
2024$757.50M 162.7% up
2023$288.39M 32.9% down
2022$430.07M—
2021-$113.82M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on NAMS

NewAmsterdam Pharma Company N.V., figure by figure

NewAmsterdam Pharma Company N.V. (NAMS) overview: price, valuation and scorecard

NewAmsterdam Pharma Company N.V. net assets (shareholders' equity): questions and answers

What are NewAmsterdam Pharma Company N.V.'s net assets?

NewAmsterdam Pharma Company N.V. (NAMS) had net assets of $683.43M at the end of fiscal 2025 (December 31, 2025). That is 9.8% lower than the $757.50M of fiscal 2024.

What are the highest and lowest net assets figures on record for NewAmsterdam Pharma Company N.V.?

Across the 5 fiscal years on record (2021–2025), the highest was $757.50M in fiscal 2024 and the lowest -$113.82M in fiscal 2021.

How is NewAmsterdam Pharma Company N.V.'s net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For NewAmsterdam Pharma Company N.V. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “NewAmsterdam Pharma Company N.V. (NAMS) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/NAMS/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.